Trexquant Investment LP Ultragenyx Pharmaceutical Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 167,267 shares of RARE stock, worth $7.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

167,267

Previous 18,765 791.38%

Holding current value

$7.9 Million

Previous $771,000 1105.06%

% of portfolio

0.12%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$40.21 - $59.36 $5.97 Million - $8.82 Million	148,502 Added 791.38%	167,267 $9.29 Million
Q2 2024 Aug 13, 2024	SELL	$37.42 - $51.61 $1.66 Million - $2.29 Million	-44,398 Reduced 70.29%	18,765 $771,000
Q1 2024 May 14, 2024	BUY	$43.02 - $53.69 $415,702 - $518,806	9,663 Added 18.06%	63,163 $2.95 Million
Q4 2023 Feb 09, 2024	BUY	$31.73 - $49.19 $759,996 - $1.18 Million	23,952 Added 81.06%	53,500 $2.56 Million
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $23,326 - $31,168	668 Added 2.31%	29,548 $1.05 Million
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $175,806 - $245,470	4,707 Added 19.47%	28,880 $1.33 Million
Q1 2023 May 15, 2023	SELL	$36.99 - $48.71 $733,659 - $966,114	-19,834 Reduced 45.07%	24,173 $969,000
Q4 2022 Feb 13, 2023	BUY	$33.72 - $46.33 $664,385 - $912,839	19,703 Added 81.07%	44,007 $2.04 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $92,547 - $153,180	2,316 Added 10.53%	24,304 $1.01 Million
Q2 2022 Aug 11, 2022	BUY	$45.8 - $85.4 $451,267 - $841,446	9,853 Added 81.19%	21,988 $1.31 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $754,797 - $1.02 Million	12,135 New	12,135 $881,000
Q3 2021 Nov 12, 2021	SELL	$77.92 - $102.4 $714,916 - $939,520	-9,175 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$92.19 - $115.71 $845,843 - $1.06 Million	9,175 New	9,175 $875,000
Q4 2020 Feb 11, 2021	SELL	$84.4 - $177.39 $432,128 - $908,236	-5,120 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$72.98 - $90.0 $458,241 - $565,110	-6,279 Reduced 55.08%	5,120 $421,000
Q2 2020 Aug 07, 2020	BUY	$46.91 - $78.22 $534,727 - $891,629	11,399 New	11,399 $892,000
Q3 2019 Nov 08, 2019	SELL	$42.5 - $63.11 $257,635 - $382,572	-6,062 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$54.93 - $74.36 $332,985 - $450,770	6,062 New	6,062 $385,000
Q1 2019 May 13, 2019	SELL	$39.87 - $69.36 $472,539 - $822,054	-11,852 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$38.89 - $77.3 $460,924 - $916,159	11,852 New	11,852 $515,000
Q3 2018 Nov 09, 2018	SELL	$71.81 - $90.15 $979,847 - $1.23 Million	-13,645 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$48.54 - $85.31 $662,328 - $1.16 Million	13,645 New	13,645 $1.05 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.31B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Ultragenyx Pharmaceutical Inc. Transaction History